9 results

133 Effect of recombinant human bone morphogenetic protein-2 and osteoprotegerin-Fc in MC3T3-E1 cells: beyond challenges to success
Chang Hoon Lee
KMSID: 1516087678   J Rheum Dis. 2024;31(3):133-134.   Published online 2024 July 1    DOI: http://dx.doi.org/10.4078/jrd.2024.0079
      
135 Overview of childhood vasculitis
Jong Gyun Ahn
KMSID: 1516087681   J Rheum Dis. 2024;31(3):135-142.   Published online 2024 June 5    DOI: http://dx.doi.org/10.4078/jrd.2024.0045
      
143 Clinical characteristics and prognostic value of autoantibody profile in children with monogenic lupus
Sulaiman M. Al-Mayouf, Alaa Hamad, Wassima Kaidali, Raghad Alhuthil, Alhanouf Alsaleem
KMSID: 1516087682   J Rheum Dis. 2024;31(3):143-150.   Published online 2023 December 14    DOI: http://dx.doi.org/10.4078/jrd.2023.0065
      
151 The monocyte-to-high-density lipoprotein-cholesterol ratio at diagnosis is associated with cerebrovascular accident during follow-up in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Jang Woo Ha, Sung Soo Ahn, Jason Jungsik Song, Yong-Beom Park, Sang-Won Lee
KMSID: 1516087679   J Rheum Dis. 2024;31(3):151-159.   Published online 2024 March 12    DOI: http://dx.doi.org/10.4078/jrd.2024.0001
      
160 Clinical characteristics and courses of Korean patients with giant cell arteritis: a multi-center retrospective study
Jee-In Lee, Jun Won Park, Youjin Jung, Kichul Shin, Se Rim Choi, Eun Ha Kang, Yun Jong Lee, Jong Jin Yoo, You-Jung Ha
KMSID: 1516087683   J Rheum Dis. 2024;31(3):160-170.   Published online 2024 May 14    DOI: http://dx.doi.org/10.4078/jrd.2024.0007
      
171 The effectiveness of tumor necrosis factor-α blocker therapy in patients with axial spondyloarthritis who failed conventional treatment: a comparative study focused on improvement in ASAS Health Index
Ah-Ra Choi, Ki-Jeong Park, Ji-Hyoun Kang, Yu Jeong Lee, Hyun Hee Jang, Moon-Ju Kim, Tae-Jong Kim
KMSID: 1516087680   J Rheum Dis. 2024;31(3):171-177.   Published online 2024 April 29    DOI: http://dx.doi.org/10.4078/jrd.2024.0029
      
178 Corticosteroid-free adalimumab-cyclophosphamide combination therapy for acute phase neuro-Behçet’s disease: a case report
Ji Hyoun Kim, Sang Wan Chung, Yun Jong Lee
KMSID: 1516087685   J Rheum Dis. 2024;31(3):178-181.   Published online 2024 February 2    DOI: http://dx.doi.org/10.4078/jrd.2023.0069
      
182 Unraveling the diagnostic odyssey: stimulator of interferon gene-associated vasculopathy with onset in infancy in a 30-year-old female
Hae Ryung Kim, Seon Hee Lim, Ji Soo Park, Dong In Suh, Seungbok Lee, Soo Yeon Kim, Jong Hee Chae, Seong Heon Kim
KMSID: 1516087686   J Rheum Dis. 2024;31(3):182-187.   Published online 2024 April 9    DOI: http://dx.doi.org/10.4078/jrd.2023.0075
      
188 Jaccoud’s arthropathy in osteogenesis imperfecta
Frederico Rajão Martins, Margarida Lucas Rocha, Ana Teodósio Chícharo, Vítor Silvestre-Teixeira
KMSID: 1516087684   J Rheum Dis. 2024;31(3):188-189.   Published online 2024 February 1    DOI: http://dx.doi.org/10.4078/jrd.2023.0090
      
Articles from Journal of Rheumatic Diseases are provided here courtesy of Korean College of Rheumatology